News about cell analysis instruments and tools including flow cytometry, cell counters, high content screening, etc.
–Early access researchers will present data at the annual meeting of the American Association for Cancer Research in Chicago this week– PLEASANTON, CA.—April 13, 2018—10x Genomics, a company focused on accelerating genomic discovery, today launched the Chromium Single Cell CNV Solution, which is the first scalable and easy-to-use technology for rapid and massively parallel profiling of... Read more
Thermo Fisher Scientific to Showcase Clinical Research Advances in Immuno-Oncology at AACR Company announces next generation Arcturus Cellect LCM System and Oncomine Knowledgebase Reporter update; Scientific presentations to highlight Oncomine assays for tumor mutation load and immune repertoire analysis CARLSBAD, Calif., April 12, 2018 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, will... Read more
Providing the DoD with premier biological materials and services MANASSAS, Va., April 6, 2018 /PRNewswire-USNewswire/ — ATCC, a global leader in biological materials development, management and standards, today announced it has been awarded a 10-year contract through the U.S. Department of Defense’s (DoD) Joint Enterprise-Research, Development, Acquisition, and Production/Procurement (JE-RDAP), an omnibus Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle to... Read more
New Compounds Now Available for Antimicrobial Susceptibility Testing: Delafloxacin and Meropenem/Vaborbactam FDA-cleared microbroth dilution plates provide true minimum inhibitory concentration (MIC) results, facilitating more targeted patient therapy OAKWOOD VILLAGE, Ohio, April 5, 2018 /PRNewswire/ — The antimicrobial delafloxacin, and the combination of meropenem and vaborbactam are now available on FDA-cleared microbroth dilution susceptibility plates, expanding antimicrobial... Read more
Greiner Bio-One North America, Inc. is announcing the publication in SLAS Discovery of an article titled “Advanced Development of Primary Pancreatic Organoid Tumor Models for High Throughput Phenotypic Drug Screening”. Authored by The Scripps Research Institute in Florida, in collaboration with Cold Spring Harbor Laboratory, Greiner Bio-One, Nano3D Biosciences, Inc., University of Texas Health Science... Read more
MINNEAPOLIS, March 14, 2018 /PRNewswire/ — Bio-Techne has released MimEX™ GI, a new product line for generating 3-dimensional (3-D) gastrointestinal tissue on a 2-D surface. 3-D cell culture and organoid models of the gastrointestinal epithelium are quickly being adopted for toxicology, drug discovery, and disease modeling. These more complex models provide a tremendous benefit over cell line- and primary... Read more
The seventh annual International Conference and Exhibition of the Society for Lab Automation and Screening (SLAS) was held February 3–7 in San Diego, CA. More than 300 companies turned up to the exhibition to display their latest wares. Among the dazzling array of new products presented at the conference the were 50 that had been... Read more
Charles Gross , Benzinga Staff Writer February 25, 2018 5:47pm RHS Limited (ASX: RHS) is pleased to announce that it has entered into a binding Scheme Implementation Agreement (“SIA”) with PerkinElmer, Inc. (“PerkinElmer”) PKI 0.29% for the acquisition by PerkinElmer of all of the issued share capital of RHS by way of a Scheme of Arrangement (“Scheme”) for $0.28 per share. The... Read more
Location: Cambridge 12/02/2018 Horizon out-licenses proprietary cell line and Helitron transposon gene editing technologies demonstrating Horizon’s ability to generate revenues from internally derived IP Horizon retains commercial rights over improvements to its technology platforms to develop new cell line technologies and gene delivery IP that can be licensed to customers for applications in biomanufacturing, diagnostic... Read more
–Joining forces for single-cell research excellence– PLEASANTON, CA.—February 21, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that it has joined the Corporate Partnership Program of the European Molecular Biology Laboratory (EMBL), one of the world’s leading research institutions. “As a leader in single cell genomics, 10x Genomics is investing in... Read more